英文医学论文摘要的撰写杂志社编辑培训0909（照日格图）课件.pptVIP

方法部分的时态也要用 一般过去时。 结 果 Results 一般论文摘要中占篇幅较大的是这一部分。这一段介绍最主要的研究结果。 时态用一般过去时。 摘要中一般不主张用图表(会议摘要可有少量图表)。 可以介绍一些关键的数字。国内不少杂志包括统计学处理结果（具有可信区间的有关数据或P值等）。JAMA和Lancet都主张包括P值。 在摘要的结果部分描述结果时，应当避免的一些情况： The results of our study showed that … It was shown that … The present study showed that … 等等。 因为前面有个小标题Results，可以直接开始描述结果。 下面是N Engl J Med一篇摘要的结果部分： Results The mortality rate was 30.8 percent in the placebo group and 24.7 percent in the drotrecogin alfa activated group. On the basis of the prospectively defined primary analysis, treatment with drotrecogin alfa activated was associated with a reduction in the relative risk of death of 19.4 percent (95 percent confidence interval,6.6 to 30.5) and an absolute reduction in the risk of death of 6.1 percent (P=0.005). The incidence of serious bleeding was higher in the drotrecogin alfa activated group than in the placebo group (3.5 percent vs. 2.0 percent, P=0.06). 有问题的例子： (Results) … ③The positive rates of B19-DNA and IgM in patients with Schonlein-Henoch purpura, juvenile rheumatoid arthritis, dermatomyositis, systemic lupus erythematosus and Kawasaki disease are 25% and 20%、37.2% and 20%、40% and 20%、42.9% and 28.6%、37.5% and 25.0%, respectively. There is no difference of the positive rates of B19-DNA and IgM among the above five types of childrens common rheumatism (P0.05). (初步修改) ③The positive rates of B19-DNA and IgM in patients with Schonlein-Henoch purpura, juvenile rheumatoid arthritis, dermatomyositis, systemic lupus erythematosus and Kawasaki disease were 25% and 20%, 37.2% and 20%, 40% and 20%, 42.9% and 28.6%, 37.5% and 25.0%, respectively. There was no significant difference in the positive rates of B19-DNA and IgM among the above five types of childrens common rheumatism disorders of children (P0.05). (再次修改) ③ B19-DNA and IgM antibody were positive in 25% and 20%, 37.2% and 20%, 40% and 20%, 42.9% and 28.6%, 37.5% and 25.0%, in patients with Schonlein-He